Type 1 diabetes: basis of causes and away of prevention

Paper Details

Review Paper 01/01/2013
Views (415) Download (11)

Type 1 diabetes: basis of causes and away of prevention

Md. Shamim Hossain, Mst. Touhida khatun
Int. J. Biomol. & Biomed.3( 1), 1-11, January 2013.
Certificate: IJBB 2013 [Generate Certificate]


Type 1 diabetes (T1D) is characterized by autoimmune destruction of insulin-producing β-cells in the pancreas, an organ in the abdomen, produces very little or no insulin caused by a complex interaction of genetic and environmental factors. Insulin is a hormone that helps the body to absorb and use glucose and other nutrients from food, store fat, and build up protein and without insulin, blood glucose (sugar) levels become higher than normal. The genetic factors involved consist of multiple susceptibility genes, at least five of which, HLA, INS, CTLA4, PTPN22 and IL2RA/CD25. The excess mortality associated with the complications of type 1 diabetes and the increasing incidence of childhood type 1 diabetes emphasize the importance of therapeutic strategies to prevent this chronic disorder. Although no current “cure” exists, recent genetic data and preliminary trial results suggest T cells as a target for preventive strategies. Another potentially attainable target is induction of tolerance to the ß-cell proteins such as insulin that are inappropriately recognized. Other strategies involve ß-cell replacement, but currently there are insufficient donor cells available. But researchers revealed that breastfeeding, taking proper exercise, vaccination against causing enterovirous, vitamin D, regulation of maternal diet and keep away from smoking are the best away prevent from type 1 diabetes. This review aims to provide the link of causing type 1 diabetes and the away of prevention to the type 1 diabetes patient.


Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. 2004. Mature high-affinity immune responses to (pro) insulin anticipate the autoimmune cascade that leads to type 1 diabetes. Journal of Clinical Investigation 114, 589–597.

Action on smoking and health (ASH) Fact Sheet. 2012. Smoking and diabetes, www.ash.org.uk.

 Bach JF. 2005. Infections and autoimmune diseases. J Autoimmun 25, 74-80.

Bell GI, Horita S, Karam JH. 1984. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33, 176–183.

Bennett ST, Lucassen AM, Gough SC. 1995. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9, 284–292.

Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler AG. 2004. IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care 27, 2695–2700.

Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PG, Gamble DR. 1985. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313, 353–360.

Bottini N, Musumeci L, Alonso A. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36, 337– 338.

Bourlon PM, Faure-Dussert A, Billauder B, Sutter BC, Tramu G, Thomasset M. 1996. Relationship between Calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 de ficiency and 1,25 dihydroxyvitamin D3. J Endocrinol 148, 223 – 232.

Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC. 2007. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves’disease using a multilocus test and tag SNPs. Clin. Endocrinol 66, 508-512.

Brown RJ, Rother KI. 2008. Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data. Pediatr Diabetes 9, 14–22.

Burke GW, Ciancio G, Sollinger HW. 2004. Advances in pancreas transplantation. Transplantation 15, 77, S62-7.

Cudworth AG, Woodrow JC. 1975. Evidence for HL-A-linked genes in ‘juvenile’ diabetes mellitus. Br Med J 3, 133–135.

Dor Y, Brown J, Martinez OI. 2004.Adult pancreatic beat-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-6.

Edghill EL, Dix RJ, Flanagan SE. 2006. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 55, 1895–1898.

Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. 2004. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47, 1661–1667.

Gale EA. 2002. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353–3361.

Gillespie KM.2006. Type 1 diabetes: pathogenesis and prevention. Canadian Medical Association Journal 175 (2). doi:10.1503/cmaj.060244.

Ginsberg-Fellner F, Witt ME, Fedun B. 1985. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 7(1), S170-6.

Harder T, Bergmann R, Kallischnigg G, Plagemann A. 2005.Duration of breastfeeding and risk of overweight: a meta-analysis. American Journal of Epidemiology 162, 397–403.

Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. 1996. Identification of the 37 kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 45, 1187–1192.

Honeyman M. 2005. How robust is the evidence for viruses in the induction of type 1 diabetes? Curr Opin Immunol 17, 616–623.

Honeyman MC, Coulson BS, Stone NL. 2000. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49, 1319-24.

Hyöty H, Taylor KW. 2002. The role of viruses in human diabetes. Diabetologia 45, 1353–1361.

Hyoty H. 2002. Enterovirus infections and type 1 diabetes. Ann Med 34, 138–147.

Ikegami H, Noso S, Babaya N, Hiromine Y, Kawabata Y.2008.Genetic basis of Type 1 Diabetes: similarities and differences between east and west. The Review of Diabetic Studies Vol. 5 , No. 2. DOI 10.1900/RDS.2008.5.64

Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. 2000. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 342, 301-307.

Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, MaruyamaT, Makino H. 2005. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48, 294-300.

Imagawa A, Hanafusa T. 2006. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud. 3, 4, 169-177.

Ishida H, Norman AW.1988.Demonstration of a high affinity receptor for 1,25- dihydroxyvitamin D3 in rat pancreas. Mol Cell Endocrinol 60,109–117.

Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K. 1993. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16, 780-788.

Lowe CE, Cooper JD, Brusko T. 2007. Large-scale genetic fine mapping and genotype–phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39, 1074–1082.

Mathieu C, Badenhoop K.2005. Vitamin D and type 1 diabetes mellitus: state of the art. TRENDS in Endocrinology and Metabolism.

Mehers KL , Gillespie KM. 2008. The genetic basis for type 1 diabetes. British Medical Bulletin 88, 115– 129

Meier J, Bhushan A, Butler AE. 2005.Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: Indirect evidence for islet regeneration? Diabetologia 48, 2221-8.

Michael C, Riddell PhD, Bruce A, Perkins MD MPH.2006. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management. Canadian Journal of Diabetes 30(1), 63-71.

Muller K, Bendtzen K. 1992.Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity 14, 37– 43.

Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387–389.

Peltola H, Davidkin I, Paunio M. 2000. Mumps and rubella eliminated from Finland. JAMA 284, 2643-7.

Qu HQ, Marchand L, Grabs R, Polychronakos C. 2008.The association between the IFIH1 locus and type 1 diabetes. Diabetologia 51, 473–475.

Qu HQ, Montpetit A, Ge B, Hudson TJ, Polychronakos C. 2007. Toward further mapping of the association between the IL2RA locus and type 1 diabetes. Diabetes 56, 1174–1176.

Rewers MDM, Gottlieb MDP. 2009. Immunotherapy for the Prevention and Treatment of Type 1 Diabetes. Diabetes Care 32(10), 1769–1782.

Roll U, Christie MR, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG. 1996. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45, 967–973.

Rubio-Cabezas O, Argente J.2008. Current Insights into the Genetic Basis of Diabetes Mellitus in Children and Adolescents. Journal of Pediatric Endocrinology & Metabolism, 21, 917-940.

Ryan EA, Paty BW, Senior PA. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060-9.

Sadauskaite-Kuehne V, Ludvigsson J, Padaiga Z, Jasinskiene E, Samuelsson U.2004.Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. Diabetes/Metabolism Research and Reviews. 20, 150–157.

Schmid S, Buuck D, Knopff A, Bonifacio E, Ziegler AG. 2004.BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with type 1 diabetes by delaying exposure to gluten. Diabetologia 47, 1130–1131.

Seaberg RM, Smukler SR, Kieffer TJ. 2004.Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 22, 1115-24.

Singal DP, Blajchman MA. 1973. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22, 429–432.

Stene LC, Magnus P, Lie RT, Søvik O, Joner G. 2001.The Norwegian Childhood Diabetes Study Group. Birth weight and childhood onset type 1 diabetes: population based cohort study. BMJ 322, 889-892.

Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). 2007.Pediatr Diabetes 8, 117–137.

Todd JA, Bell JI, McDevitt HO. 1987. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604.

Todd JA, Walker NM, Cooper JD. 2007. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39, 857–864.

Ueda H, Howson JM, Esposito L. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–511.

Vafiadis P, Bennett ST, Todd JA. 1997. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15, 289– 292.

Vella A, Cooper JD, Lowe CE. 2005. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76, 773–779.

Viskari H, Ludvigsson J, Uibo R. 2005.Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 48, 1280-7.

Von Herrath M. 2009. Diabetes: a virus-gene collaboration. Nature 459, 518–519.

Williams AJ, Aitken RJ, Chandler MA, Gillespie KM, Lampasona V, Bingley PJ.2008. Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia 51, 1444–1448.

Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP.2007. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30, 2314–2320.